| Autor: |
Aung MN; Department of Public Health, Juntendo University Graduate School of Medicine, Tokyo, Japan. dr.myonyeinaung@gmail.com, Moolphate S, Paudel D, Jayathunge Ph M, Duangrithi D, Wangdi K, Aung TN, Lorga T, Higuchi K |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of infection in developing countries [J Infect Dev Ctries] 2013 Mar 14; Vol. 7 (3), pp. 191-202. Date of Electronic Publication: 2013 Mar 14. |
| DOI: |
10.3855/jidc.2903 |
| Abstrakt: |
Tuberculosis (TB) and human immunodeficiency virus (HIV) co-epidemics form a huge burden of disease in the Southeast Asia region. Five out of eleven nations in this region are high TB/HIV burden countries: Myanmar, Thailand, India, Indonesia and Nepal. The trends of TB incidence in these countries have been rising in recent years, in contrast to a falling global trend. Experts in the field of TB control and health service providers have been perplexed by the association of TB and HIV infections which causes a mosaic clinical presentation, a unique course with poor treatment outcomes including death. We conducted a review of contemporary evidence relating to TB/HIV control with the aims of assisting integrated health system responses in Southeast Asia and demystifying current evidence to facilitate translating it into practice. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
